EUVIMEDEUVIMED entdecken
Open Access

Gut microbiome and metabolome profiling in Framingham heart study reveals cholesterol-metabolizing bacteria

Chenhao Li, Martin Stražar, Ahmed M T Mohamed, Julian A Pacheco, Rebecca L Walker, Tina Lebar, Shijie Zhao, Julia Lockart, Andrea Dame, Kumar Thurimella, Sarah Jeanfavre, Eric M Brown und 14 weitere

Cell · 2024-04 · 187 (8) · 1834-1852.e19

DOI: 10.1016/j.cell.2024.03.014 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell, 2024-04. Verfasst von Chenhao Li und 25 weiteren Autor:innen. Beteiligte Einrichtung: Broad Institute of MIT and Harvard, Cambridge, MA, USA; Center for Computational and Integrative Biology and Department of Molecular Biology, Massach…. Hauptthemen laut MEDLINE: Bacteria, Cardiovascular Diseases, Cholesterol, Gastrointestinal Microbiome. Die Arbeit wurde bisher 272-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NHLBI NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Accumulating evidence suggests that cardiovascular disease (CVD) is associated with an altered gut microbiome. Our understanding of the underlying mechanisms has been hindered by lack of matched multi-omic data with diagnostic biomarkers. To comprehensively profile gut microbiome contributions to CVD, we generated stool metagenomics and metabolomics from 1,429 Framingham Heart Study participants. We identified blood lipids and cardiovascular health measurements associated with microbiome and metabolome composition. Integrated analysis revealed microbial pathways implicated in CVD, including flavonoid, γ-butyrobetaine, and cholesterol metabolism. Species from the Oscillibacter genus were associated with decreased fecal and plasma cholesterol levels. Using functional prediction and in vitro characterization of multiple representative human gut Oscillibacter isolates, we uncovered conserved cholesterol-metabolizing capabilities, including glycosylation and dehydrogenation. These findings suggest that cholesterol metabolism is a broad property of phylogenetically diverse Oscillibacter spp., with potential benefits for lipid homeostasis and cardiovascular health.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BacteriaCardiovascular DiseasesCholesterolGastrointestinal MicrobiomeHumansFecesLongitudinal StudiesMetabolomeMetabolomicsRNA, Ribosomal, 16S

Stichwörter der Autor:innen

Cardiovascular diseaseCholesterolMetabolomeMicrobiomeOscillibacter

Substanzen

CholesterolRNA, Ribosomal, 16S

Autor:innen und Institutionen

  • Broad Institute of MIT and Harvard, Cambridge, MA, USA; Center for Computational and Integrative Biology and Department of Molecular Biology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA 02115, USA.
  • Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA, USA.
  • Boston University and NHLBI's Framingham Heart Study, Framingham, MA, USA; Sections of Preventive Medicine and Epidemiology and Cardiology, Department of Medicine, Boston University School of Medicine, Boston, MA, USA;…
  • Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA, USA; Howard Hughes Medical Institute, Harvard University, Cambridge, MA, USA.

Förderung

  • NIDDK NIH HHS
  • NHLBI NIH HHS
  • National Institutes of Health

Zitieren

APA

Li, C., Stražar, M., Mohamed, A. M. T., Pacheco, J. A., Walker, R. L., Lebar, T., Zhao, S., Lockart, J., Dame, A., Thurimella, K., Jeanfavre, S., Brown, E. M., Ang, Q. Y., Berdy, B., Sergio, D., Invernizzi, R., Tinoco, A., Pishchany, G., Vasan, R. S., …, & Xavier, R. J. (2024). Gut microbiome and metabolome profiling in Framingham heart study reveals cholesterol-metabolizing bacteria. Cell, 187(8), 1834-1852.e19. https://doi.org/10.1016/j.cell.2024.03.014

Vancouver

Li C, Stražar M, Mohamed AMT, Pacheco JA, Walker RL, Lebar T, et al. Gut microbiome and metabolome profiling in Framingham heart study reveals cholesterol-metabolizing bacteria. Cell. 2024;187(8):1834-1852.e19. doi:10.1016/j.cell.2024.03.014

BibTeX
@article{Li2024,
  author = {Li, Chenhao and Stražar, Martin and Mohamed, Ahmed M T and Pacheco, Julian A and Walker, Rebecca L and Lebar, Tina and Zhao, Shijie and Lockart, Julia and Dame, Andrea and Thurimella, Kumar and Jeanfavre, Sarah and Brown, Eric M and Ang, Qi Yan and Berdy, Brittany and Sergio, Dallis and Invernizzi, Rachele and Tinoco, Antonio and Pishchany, Gleb and Vasan, Ramachandran S and Balskus, Emily and Huttenhower, Curtis and Vlamakis, Hera and Clish, Clary and Shaw, Stanley Y and Plichta, Damian R and Xavier, Ramnik J},
  title = {Gut microbiome and metabolome profiling in Framingham heart study reveals cholesterol-metabolizing bacteria},
  journal = {Cell},
  year = {2024},
  volume = {187},
  number = {8},
  pages = {1834--1852.e19},
  doi = {10.1016/j.cell.2024.03.014}
}
Kostenlos starten →